PSFJ ETF

Leveraged fundWeights reflect notional exposure via swaps/derivatives and do not sum to 100%.
Net exposure
98.8%
Gross exposure
109.4%
Long
104.1%
Short
-5.3%
Cash & collateral
1.1%
As of Jun 30, 2026
Showing top 7 of 7 holdings · as of Jun 30, 2026
PSFJ holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1Novabay Pharmaceuticals Inc
98.00%
98.0%506$36.98M--
2Spy 06/30/2027 746.77 P
5.56%
103.6%506$2.10M--
3Cash & Other
0.82%
104.4%310,003$310.0K--
4Afry Class B
0.58%
105.0%506$220.7K--
5
NMF
U.S. Bank Money Market Deposit AccountFinancials · Banks
0.33%
105.3%124,833$124.8KFinancialsBanks
6Spy 06/30/2027 869.22 C
-1.69%
103.6%-506$-637570--
7Spy 06/30/2027 597.42 P
-3.61%
100.0%-1,012$-1360957--
Not reported for this fund: share changes.

PSFJ ETF All Holdings

PSFJ holdings total 6 positions. The top 10 holdings account for 100.0% of the fund, led by Novabay Pharmaceuticals Inc at 98.0%, Spy 06/30/2027 746.77 P at 5.6%, Cash & Other at 0.8%.

PSFJ portfolio concentration is relatively high, with the top 10 representing 100.0% of total assets. The largest sector exposure is Financials at 0.3%.

PSFJ sector allocation provides a detailed breakdown. PSFJ overlap tool shows how holdings compare to other funds in your portfolio.

PSFJ ETF Holdings

7 of 6 holdings

  • 1

    Novabay Pharmaceuticals Inc

    Other
    98.00%
  • 2

    Spy 06/30/2027 746.77 P

    Other
    5.56%
  • 3

    Cash & Other

    Other
    0.82%
  • 4

    Afry Class B

    Other
    0.58%
  • 5

    U.S. Bank Money Market Deposit Account

    NMFFinancials
    0.33%
  • 6

    Spy 06/30/2027 869.22 C

    Other
    -1.69%
  • 7

    Spy 06/30/2027 597.42 P

    Other
    -3.61%